PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OGI vs. CRON
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OGI and CRON is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

OGI vs. CRON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in OrganiGram Holdings Inc. (OGI) and Cronos Group Inc. (CRON). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-12.67%
-20.08%
OGI
CRON

Key characteristics

Sharpe Ratio

OGI:

-0.17

CRON:

-0.02

Sortino Ratio

OGI:

0.28

CRON:

0.37

Omega Ratio

OGI:

1.03

CRON:

1.04

Calmar Ratio

OGI:

-0.13

CRON:

-0.01

Martin Ratio

OGI:

-0.37

CRON:

-0.04

Ulcer Index

OGI:

33.71%

CRON:

22.57%

Daily Std Dev

OGI:

72.95%

CRON:

49.86%

Max Drawdown

OGI:

-97.01%

CRON:

-92.95%

Current Drawdown

OGI:

-95.36%

CRON:

-91.60%

Fundamentals

Market Cap

OGI:

$195.54M

CRON:

$760.77M

EPS

OGI:

-$0.33

CRON:

-$0.12

Total Revenue (TTM)

OGI:

$123.39M

CRON:

$87.20M

Gross Profit (TTM)

OGI:

$30.32M

CRON:

$12.24M

EBITDA (TTM)

OGI:

-$10.73M

CRON:

-$41.37M

Returns By Period

In the year-to-date period, OGI achieves a -3.73% return, which is significantly lower than CRON's -1.49% return.


OGI

YTD

-3.73%

1M

5.44%

6M

-6.06%

1Y

-7.74%

5Y*

-34.75%

10Y*

0.20%

CRON

YTD

-1.49%

1M

6.42%

6M

-16.39%

1Y

-0.50%

5Y*

-25.34%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OGI vs. CRON — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OGI
The Risk-Adjusted Performance Rank of OGI is 3838
Overall Rank
The Sharpe Ratio Rank of OGI is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of OGI is 4040
Sortino Ratio Rank
The Omega Ratio Rank of OGI is 3838
Omega Ratio Rank
The Calmar Ratio Rank of OGI is 3838
Calmar Ratio Rank
The Martin Ratio Rank of OGI is 3939
Martin Ratio Rank

CRON
The Risk-Adjusted Performance Rank of CRON is 4343
Overall Rank
The Sharpe Ratio Rank of CRON is 4444
Sharpe Ratio Rank
The Sortino Ratio Rank of CRON is 4242
Sortino Ratio Rank
The Omega Ratio Rank of CRON is 4040
Omega Ratio Rank
The Calmar Ratio Rank of CRON is 4444
Calmar Ratio Rank
The Martin Ratio Rank of CRON is 4444
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OGI vs. CRON - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for OrganiGram Holdings Inc. (OGI) and Cronos Group Inc. (CRON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for OGI, currently valued at -0.17, compared to the broader market-2.000.002.004.00-0.17-0.02
The chart of Sortino ratio for OGI, currently valued at 0.28, compared to the broader market-4.00-2.000.002.004.000.280.37
The chart of Omega ratio for OGI, currently valued at 1.03, compared to the broader market0.501.001.502.001.031.04
The chart of Calmar ratio for OGI, currently valued at -0.13, compared to the broader market0.002.004.006.00-0.13-0.01
The chart of Martin ratio for OGI, currently valued at -0.37, compared to the broader market-10.000.0010.0020.0030.00-0.37-0.04
OGI
CRON

The current OGI Sharpe Ratio is -0.17, which is lower than the CRON Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of OGI and CRON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.200.000.200.400.600.801.00AugustSeptemberOctoberNovemberDecember2025
-0.17
-0.02
OGI
CRON

Dividends

OGI vs. CRON - Dividend Comparison

Neither OGI nor CRON has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OGI vs. CRON - Drawdown Comparison

The maximum OGI drawdown since its inception was -97.01%, roughly equal to the maximum CRON drawdown of -92.95%. Use the drawdown chart below to compare losses from any high point for OGI and CRON. For additional features, visit the drawdowns tool.


-96.00%-95.00%-94.00%-93.00%-92.00%-91.00%-90.00%-89.00%AugustSeptemberOctoberNovemberDecember2025
-95.36%
-91.60%
OGI
CRON

Volatility

OGI vs. CRON - Volatility Comparison

OrganiGram Holdings Inc. (OGI) has a higher volatility of 15.58% compared to Cronos Group Inc. (CRON) at 8.95%. This indicates that OGI's price experiences larger fluctuations and is considered to be riskier than CRON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
15.58%
8.95%
OGI
CRON

Financials

OGI vs. CRON - Financials Comparison

This section allows you to compare key financial metrics between OrganiGram Holdings Inc. and Cronos Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab